D'ANDREA, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 721
EU - Europa 580
AS - Asia 569
SA - Sud America 115
AF - Africa 16
OC - Oceania 5
Totale 2.006
Nazione #
US - Stati Uniti d'America 686
SG - Singapore 304
IT - Italia 257
CN - Cina 136
DE - Germania 102
BR - Brasile 93
VN - Vietnam 50
IE - Irlanda 46
FI - Finlandia 31
SE - Svezia 31
GB - Regno Unito 22
HK - Hong Kong 21
CA - Canada 18
NL - Olanda 17
TR - Turchia 16
FR - Francia 15
MX - Messico 15
RU - Federazione Russa 14
IN - India 13
AT - Austria 10
AR - Argentina 9
ES - Italia 9
PL - Polonia 9
LT - Lituania 8
ZA - Sudafrica 8
JP - Giappone 7
KR - Corea 6
AU - Australia 5
BE - Belgio 4
EC - Ecuador 4
EG - Egitto 4
ID - Indonesia 4
CO - Colombia 3
BD - Bangladesh 2
CL - Cile 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
PK - Pakistan 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
PH - Filippine 1
TH - Thailandia 1
TN - Tunisia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.006
Città #
Singapore 227
Ashburn 98
Munich 69
Los Angeles 53
Dallas 52
The Dalles 50
Beijing 45
Dublin 44
Chandler 43
Milan 33
Santa Clara 26
Rome 22
Hong Kong 20
Ho Chi Minh City 18
Hefei 17
New York 17
Tongling 16
Denver 15
Silvi 15
Pescara 14
Buffalo 13
Chicago 13
Redondo Beach 13
Brooklyn 12
Lappeenranta 12
Princeton 12
Turku 12
Frankfurt am Main 11
Nuremberg 11
Chieti 10
Düsseldorf 10
Orem 10
São Paulo 10
Stockholm 8
Teramo 8
Warsaw 8
Ankara 7
Boston 7
Helsinki 7
Washington 7
Xi'an 7
Bologna 6
Camerino 6
Montreal 6
Phoenix 6
Querétaro 6
Seoul 6
Tokyo 6
Toronto 6
Castignano 5
Hanoi 5
Houston 5
Irsina 5
Istanbul 5
Mumbai 5
Altamura 4
Amsterdam 4
Bari 4
Boardman 4
Brussels 4
Johannesburg 4
Manchester 4
San Potito Sannitico 4
Turin 4
Atlanta 3
Augusta 3
Cairo 3
Can Tho 3
Lenno 3
Melbourne 3
Ninh Bình 3
Ottawa 3
Poplar 3
Portsmouth 3
Reggio Calabria 3
Salvador 3
San Francisco 3
San Jose 3
Seattle 3
Verona 3
Adana 2
Assis 2
Basra 2
Bhubaneswar 2
Biên Hòa 2
Brasília 2
Calamonte 2
Caldas Novas 2
Campi Bisenzio 2
Carmignano 2
Casalbordino 2
Castellammare di Stabia 2
Charleston 2
Chennai 2
City of London 2
Columbus 2
Dong Ket 2
Florence 2
Guarulhos 2
Guayaquil 2
Totale 1.304
Nome #
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 146
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 106
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 83
Addiction biotypes: a paradigm shift for future treatment strategies? 82
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 82
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 82
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 77
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 75
Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression 74
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 74
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization 72
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project) 71
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 66
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 63
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 62
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 61
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 61
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 59
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 59
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 56
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression 55
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 54
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience) 46
Language proficiency and mental disorders among migrants: A systematic review 43
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 40
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 37
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia 36
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 35
The transition time to gambling disorder: The roles that age, gambling preference and personality traits play 32
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions 31
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 31
Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)] 27
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties? 27
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 26
Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression 23
null 22
Linking Striatal Dopaminergic Asymmetry with Personality Traits: Insights from Gambling Disorder 18
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 17
Totale 2.111
Categoria #
all - tutte 11.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 6 2 4 0 7 2
2021/202223 1 0 0 0 1 0 0 3 4 2 2 10
2022/2023150 7 18 10 5 18 25 8 14 32 4 2 7
2023/2024311 10 19 35 16 37 44 37 29 18 16 15 35
2024/2025751 50 107 68 49 41 23 53 29 48 67 118 98
2025/2026855 177 65 129 244 221 19 0 0 0 0 0 0
Totale 2.111